Your browser doesn't support javascript.
loading
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.
Monroig-Bosque, Paloma Del C; Shah, Maitri Y; Fu, Xiao; Fuentes-Mattei, Enrique; Ling, Hui; Ivan, Cristina; Nouraee, Nazila; Huang, Beibei; Chen, Lu; Pileczki, Valentina; Redis, Roxana S; Jung, Eun-Jung; Zhang, Xinna; Lehrer, Michael; Nagvekar, Rahul; Mafra, Ana Carolina P; Monroig-Bosque, Maria Del Mar; Irimie, Alexandra; Rivera, Carlos; Dan Dumitru, Calin; Berindan-Neagoe, Ioana; Nikonowicz, Edward P; Zhang, Shuxing; Calin, George A.
Afiliação
  • Monroig-Bosque PDC; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shah MY; Department of Medicine, University of Puerto Rico School of Medicine, San Juan, Puerto Rico.
  • Fu X; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fuentes-Mattei E; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ling H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Ivan C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nouraee N; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Huang B; Cell & Gene Therapy, Bioverativ Inc. A Sanofi Company, Waltham, 02451, MA, USA.
  • Chen L; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pileczki V; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Redis RS; Center for Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Jung EJ; Intelligent Molecular Discovery Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang X; Intelligent Molecular Discovery Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lehrer M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nagvekar R; The Research Center for Functional Genomics, Biomedicine and Translational Medicine University of Medicine and Pharmacy 'I. Hatieganu', Cluj-Napoca, Romania.
  • Mafra ACP; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Monroig-Bosque MDM; ProQR Therapeutics N.V., 2333 CK, Leiden, The Netherlands.
  • Irimie A; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rivera C; Department of Surgery, School of Medicine, Gyeongsang National University, Jin-ju, South Korea.
  • Dan Dumitru C; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Berindan-Neagoe I; Medical and Molecular Genetics Department, Indiana University, Indianapolis, IN, USA.
  • Nikonowicz EP; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang S; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Calin GA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sci Rep ; 8(1): 13106, 2018 08 30.
Article em En | MEDLINE | ID: mdl-30166612
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias da Mama / RNA Neoplásico / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Indazóis / Neoplasias Hepáticas Limite: Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias da Mama / RNA Neoplásico / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Indazóis / Neoplasias Hepáticas Limite: Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido